Navigation Links
NeoStem's CEO Letter to Shareholders
Date:1/3/2012

NEW YORK, Jan. 3, 2012 /PRNewswire/ --

Dear NeoStem Shareholders,

We would like to take a moment to both look back at 2011 - a transformative year for NeoStem (NYSE Amex: NBS) – and to look ahead to near term catalysts that we expect to move the company forward in 2012 and beyond.

  • We have closed two acquisitions - Progenitor Cell Therapy, LLC ("PCT") and Amorcyte, LLC ("Amorcyte").
  • We believe our therapeutic product development team is very close to accomplishing its aggressive goal of getting a first patient enrolled in our AMR-001 Phase 2 clinical trial for the treatment of AMI with the clinical sites beginning to open.  This brings us closer to achieving our goal of enrollment of the targeted 160 patients in the study over the next year or so with first data follow-up six months after the last patient is enrolled (roughly mid-2013).
  • Our cell therapy manufacturing business is growing and client satisfaction confirms our belief and excitement that we have unique skills and people (expertise, quality and work ethic) to serve as a platform to be a global leader in the cell therapy space.
  • We raised $16.5 million in gross proceeds in 2011 for working capital, including research and development of our cell therapeutic candidates.
  • We received awards of over $1.7 million in Department of Defense funding for development of our VSELTM Technology to treat osteoporosis and $245,176 from the National Institutes of Health (NIH) with Excell Therapeutics to progress our T regulatory program in Lupus. 
  • We co-hosted a spectacular international conference in partnership with the Vatican's Pontifical Council for Culture on Adult Stem Cells: Science and the Future of Man and Culture, moving forward the public discussion of adult stem cells and adult stem cell research.
  • Our cord blood banking
    '/>"/>

  • SOURCE NeoStem, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. Huifeng Bio-Pharmaceutical (HFGB) Enters into Letter of Intent with Xian Qinba Xintong Medical Ltd.
    2. CTI Receives NASDAQ Letter
    3. Synvista Therapeutics Posts Letter to Stockholders on Web Site
    4. Oncothyreon announces receipt of NASDAQ letter regarding compliance with NASDAQ Global Market listing standards
    5. Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
    6. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
    7. Vical and AnGes MG Sign Letter of Intent for Pandemic Influenza Program
    8. Cell Therapeutics to Request a Hearing With NASDAQ Following Receipt of Staff Determination Letter
    9. Spherix Receives Nasdaq Letter Extending Minimum Bid Price Compliance Period
    10. Caraco Pharmaceutical Laboratories, Ltd. Receives FDA Warning Letter
    11. deCODE Requests Hearing With Nasdaq Following Receipt of Staff Determination Letter
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2014)... Sales Horizons, a leader in sales training, today ... – Mastering the Complex Sale – to ... proven sales training programs used by thousands of salespeople ... sales training course is available to every salesperson as ... customers, like technical support, engineers, clinical support, and IT ...
    (Date:7/30/2014)... and PARIS , July 30, 2014 ... SAN and NYSE: SNY) today announced that the Companies ... (FDA) rare pediatric disease priority review voucher in connection ...  The priority review voucher entitles the holder to designate ... expedited 6-month review from the filing date instead of ...
    (Date:7/30/2014)... Mass. , July 30, 2014  Decision ... pharmacy and medical directors in the ... drivers of biosimilar market penetration will be the ... organizations (MCOs) and the expected lower cost to ... for biosimilars that meet their pricing expectations in ...
    (Date:7/30/2014)... , July 30, 2014  The Chicago Bears ... American Academy of Dermatology (Academy) in an effort to ... Chicago Bears will host free SPOT me™ skin cancer ... 2 at Soldier Field. SPOT me™ is an ... about the dangers and risks of skin cancer, and ...
    Breaking Biology Technology:Sales Horizons Offers Mastering the Complex Sale - a Comprehensive, Online Sales Skills Training Course 2Sales Horizons Offers Mastering the Complex Sale - a Comprehensive, Online Sales Skills Training Course 3Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 2Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 3Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 4Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 5Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 6Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 2Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 3Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 2Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 3Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 4
    ... Pfizer Cox-2 inhibitor Bextra from the marketplace clearly jolted both Pfizer ... Vioxx dilemma months ago and its stock has declined from $38 ... February. It has recently moved up to the $27 level. , ... the last 12 months. , ,Though Pfizer still leads the industry ...
    ... Milwaukee Badger Meter Inc. (AMEX:BMI) reported ... the quarter ended March 31, a profit jump of 42 ... metering products for water systems, including a wireless display that ... for the same quarter last year were $2.4 million, on ...
    ... (NYSE:SXT) reported $12.8 million in profits on $251.9 million ... earnings per share were 27 cents. Sensient is a global ... was down $3 million since the same quarter last year. ... , ,Results for the first quarter include a one-time expense ...
    Cached Biology Technology:Why are new drugs failing? 2Why are new drugs failing? 3Why are new drugs failing? 4Why are new drugs failing? 5Why are new drugs failing? 6
    (Date:7/30/2014)... by the Red Queen in Lewis Carroll,s Through ... Illinois and National University of Singapore improved a ... evolve over decades to millions of years. , ... for competition, incorporates the "Red Queen Effect," an ... the 1970s, which suggests that organisms must constantly ...
    (Date:7/30/2014)... effects of climate change on the world,s animal ... factors, according to a new paper by a ... of Queensland, and other organizations. The authors claim ... the point when it comes to climate change. ... scientists focus on the "direct" threats of changing ...
    (Date:7/30/2014)... A group of researchers from the University of Helsinki ... experimentally to reproduce in mice morphological changes which have ... gradual modifications in the embryonic development of mice teeth, ... morphologically are very similar to those observed in the ... millions of years ago. , To modify the ...
    Breaking Biology News(10 mins):Classic Lewis Carroll character inspires new ecological model 2Classic Lewis Carroll character inspires new ecological model 3Conservation scientists asking wrong questions on climate change impacts on wildlife 2Scientists reproduce evolutionary changes by manipulating embryonic development of mice 2
    ... Conn. A missing link in the evolution of the ... with the discovery of a 390 million-year-old fossil by researchers ... specimen, named Schinderhannes bartelsi , was found fossilized in ... that yields spectacularly durable pyrite-preserved fossils findings collectively known ...
    ... of a new species of fruit fly--and the sequential development ... of the journal Science . Jeff Feder, a ... introduction of apples to America almost 400 years ago ultimately ... to its modification and the subsequent modification of a parasitic ...
    ... the National Science Foundation (NSF) will host its 8th ... This year,s forum focuses on ecological connectivity and climate. ... an ecological context, connectivity is defined as the transfer ... animals among interconnected locations. In this symposium, LTER ...
    Cached Biology News:Origin of claws seen in 390-million-year-old fossil 2Researchers observe evolution chain reaction 2National Science Foundation forum to address ecological connectivity and climate in a changing world 2
    ... Super Sensitive Polymer-HRP IHC ... novel product based on ... technology. This system yields ... noise ratio and minimizes ...
    ... The Gene Cycler unit is an inexpensive ... licensed for the PCR process. Lightweight, with a ... fits almost anywhere, including the researcher's desk. , ... of researchers who do not have access to ...
    ... FLISP Assay with SR-101 Labeled Substrates ... • Accurately measure serine protease activation ... • B-Bridge's FLISP Kits utilize cell-permeable, ... (FLISPs) to measure chymotrypsin-like activity in ...
    ... the PDS-1000 He biolistic system enables 7-10 times ... system. It fits into the shocking chamber of ... helium shock wave over 7 microcarriers. By uniformly ... this larger area, the system maximizes the number ...
    Biology Products: